Literature DB >> 15620521

Chemiluminescence determination of amikacin based on the inhibition of the luminol reaction catalyzed by copper.

J M Ramos Fernández1, J M Bosque-Sendra, A M García-Campaña, F Alés Barrero.   

Abstract

A simple and sensitive method has been proposed for the amikacin sulphate determination. It is based on the inhibition of the chemiluminescence (CL) emission generated from the oxidation of luminol in alkaline medium by H2O2 catalyzed by Cu(II), due to the interaction caused by amikacin, which forms a robust complex with the catalyst. The optimization of the experimental and instrumental variables affecting this CL inhibition effect has been carried out using statistical models, based on the application of two-level full factorial and Box-Behnken designs. The performance characteristics of the proposed method have been established, showing that the method is efficient to determine amikacin sulphate in the linear range of 9.89-20 mg/L with a detection limit of 2.97 mg/L. It has been successfully applied to the amikacin sulphate determination in pharmaceutical formulations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15620521     DOI: 10.1016/j.jpba.2004.09.021

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  1 in total

1.  A novel luminol-based chemiluminescence method for the determination of amikacin sulfate in serum by using trivalent copper-periodate complex.

Authors:  Yu-Fei Hu; Gong-Ke Li; Zhu-Jun Zhang
Journal:  J Pharm Anal       Date:  2013-01-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.